IMAX CEO Offloads $4.9 Million in Shares. Should You Buy or Sell the Stock?

IMAX CEO Sells Over $4.8 Million in Shares

On March 10, 2026, Richard L. Gelfond, CEO of IMAX (NYSE:IMAX), sold 121,220 shares of company stock, generating proceeds of roughly $4.86 million. This transaction was disclosed in a recent SEC Form 4 filing.

Transaction Details

Sale value based on a weighted average price of $40.10 per share (SEC Form 4); post-sale value calculated using the March 10, 2026 closing price of $39.71.

Frequently Asked Questions

• How does this sale compare to Gelfond's previous transactions?
  This sale of 121,220 shares is larger than his typical transaction, which has a median size of 100,000 shares.
• What is the significance of the derivative conversion?
  All shares sold were acquired through the exercise of options immediately before the sale, representing a conversion from derivative securities.
• Does this sale significantly change Gelfond's stake in IMAX?
  Although his direct shareholding decreased, Gelfond still holds 1,697,475 options, 231,562 restricted share units, and 765,002 common shares, maintaining substantial exposure to IMAX.
• How does the sale price compare to recent market performance?
  The average sale price of $40.10 per share was slightly above the closing price of $39.71 on March 10, 2026. Over the past year, IMAX shares delivered a total return of 58.09% as of the transaction date.

IMAX Financial Overview

1-year price change calculated as of March 10, 2026.

About IMAX

• IMAX specializes in advanced large-format cinema technology, including its proprietary Digital Re-Mastering (DMR) process, digital projection systems, and immersive theater designs. The company also offers film post-production and camera rental services.
• Revenue streams include sales, leases, and joint revenue sharing of IMAX theater systems, as well as maintenance, technical support, and global distribution of large-format films.
• IMAX serves commercial multiplex chains, educational and cultural organizations, museums, theme parks, and filmmakers seeking premium cinematic experiences.

With a presence in over 1,600 theaters across 87 countries, IMAX stands as a global leader in entertainment technology. The company leverages its proprietary imaging and audio innovations to deliver high-end movie experiences, working with both commercial and institutional partners worldwide.

What Does This Sale Mean for Shareholders?

Richard Gelfond’s sale of 121,220 shares on March 10 was not unexpected. The shares originated from options set to expire in June 2026, so he exercised them ahead of expiration and sold while IMAX stock was performing strongly.

Following the release of its 2025 earnings on February 25, IMAX shares reached a 52-week high of $43.16 on February 27. The company achieved record revenue of $410 million for the year, marking a 16% increase from the previous year.

IMAX anticipates continued robust sales in 2026, which has contributed to the stock’s elevated price-to-earnings ratio of 60—one of the highest levels seen in the past year, indicating a premium valuation.

Given these factors, current shareholders may find it an opportune moment to sell. Prospective buyers, however, might consider waiting for a potential price pullback before investing.

Is Now the Right Time to Invest in IMAX?

Before deciding to purchase IMAX shares, keep this in mind: